A Case of Interstitial Lung Disease Probably Related to Rituximab Treatment
Drug Safety - Case Reports · 2015
DOI: 10.1007/s40800-015-0010-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Safety - Case Reports, 2015. Verfasst von Massimo Calderazzo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, ASP Lamezia Terme, Catanzaro, Italy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Infectious Disease, ASP Lamezia Terme, Catanzaro, Italy.
- Department of Health Science, University of Catanzaro, Viale Europa, Catanzaro, Italy.
- Operative Unit of Clinical Pharmacology and Pharmacovigilance, Azienda Ospedaliera Mater Domini, Via T Campanella 115, Catanzaro, Italy.
- Department of Health Science, University of Catanzaro, Viale Europa, Catanzaro, Italy. gallelli@unicz.it.
- Operative Unit of Clinical Pharmacology and Pharmacovigilance, Azienda Ospedaliera Mater Domini, Via T Campanella 115, Catanzaro, Italy. gallelli@unicz.it.
Zitieren
APA
Calderazzo, M., Rende, P., Gambardella, P., De Sarro, G., & Gallelli, L. (2015). A Case of Interstitial Lung Disease Probably Related to Rituximab Treatment. Drug Safety - Case Reports. https://doi.org/10.1007/s40800-015-0010-8
Vancouver
Calderazzo M, Rende P, Gambardella P, De Sarro G, Gallelli L. A Case of Interstitial Lung Disease Probably Related to Rituximab Treatment. Drug Safety - Case Reports. 2015. doi:10.1007/s40800-015-0010-8
BibTeX
@article{Calderazzo2015,
author = {Calderazzo, Massimo and Rende, Pierandrea and Gambardella, Paolo and De Sarro, Giovambattista and Gallelli, Luca},
title = {A Case of Interstitial Lung Disease Probably Related to Rituximab Treatment},
journal = {Drug Safety - Case Reports},
year = {2015},
doi = {10.1007/s40800-015-0010-8}
}
EUVIMED